Endometriosis Market Is Expected to Generate USD 3.9 Billion by 2031, Claims Allied Market Research
Advertisement
Surge in awareness regarding endometriosis and starting of new awareness project for endometriosis drive the expansion of the global endometriosis market. Based on type, the superficial peritoneal lesion segment held the highest share in 2021. Based on region, North America held the largest share in 2021, contributing to nearly half of the global endometriosis market share.
Portland, OR, Feb. 08, 2023 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the global endometriosis market garnered $1.2 billion in 2021, and is estimated to generate $3.9 billion by 2031, manifesting a CAGR of 12.6% from 2022 to 2031. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for the sustainable growth and gaining competitive edge in the market.
Download Free Sample Report- https://www.alliedmarketresearch.com/request-sample/47699
Advertisement
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2022–2031 |
| Base Year | 2021 |
| Market Size in 2021 | $1.2 billion |
| Market Size in 2031 | $3.9 billion |
| CAGR | 12.6% |
| No. of Pages in Report | 220 |
| Segments covered | Type, Distribution channel, Treatment, and Region. |
| Drivers | Surge in awareness regarding endometriosis and starting of new awareness project for endometriosis
Shift in focus of key players towards care of female reproductive health, and increment in number of formations of alliance for reducing burden of endometriosis |
| Opportunities | Growth in funding by governments and numerous organizations for research & development (R&D) activities in endometriosis |
| Restraints | COVID-19 outbreak |
Impact of Covid-19 on Endometriosis Market:
- The outbreak of the COVID-19 pandemic had a negative impact on the growth of the global endometriosis market, owing to implementation of global lockdown which resulted to supply chain disruptions of endometriosis medicine, temporary closure of manufacturing operations, and unavailability of raw metal such as gelatin.
- In 2020 and 2021, the outpatient department (OPD) for patients took a potential backlog and was almost close due to rapidly rising COVID-19 cases; only elective emergency cases were taken and home care was preferred more.
- According to a study published by BioMed Central Ltd, in 2021, a decrease of 14.8% was observed for elective procedures performed in Germany and around 6.0% decrease for emergency procedures.
- However, with relaxation in lockdowns and decline in COVID-19 cases, companies have re-started their processes to meet the demand for products. The majority of the hospitals have resumed OPD, thus, an increase in the demand of endometriosis medicine is expected.
- In addition, rise in awareness in pharmaceutical companies, and governments regarding supply chain hinderance of pharmaceutical products drives the growth of endometriosis market in the post-pandemic.
The research provides detailed segmentation of the global endometriosis market based on type, distribution channel, treatment, and region. The report discusses segments and their sub-segments in detail with the help of tables and figures. Market players and investors can strategize according to the highest revenue-generating and fastest-growing segments mentioned in the report.
Based on type, the superficial peritoneal lesion segment held the highest share in 2021, accounting for more than three-fifths of the global endometriosis market, and is expected to continue its leadership status during the forecast period. This segment is expected to register the highest CAGR of 12.8% from 2022 to 2031.
Based on distribution channel, the hospital pharmacy segment accounted for the highest share in 2021, contributing to more than two-fifths of the global endometriosis market, and is expected to maintain its lead in terms of revenue during the forecast period. However, the online pharmacy segment is expected to manifest the highest CAGR of 13.0% from 2022 to 2031.
Based on treatment, the oral contraceptives segment accounted for the highest share in 2021, holding more than two-fifths of the global endometriosis market, and is expected to continue its leadership status during the forecast period. However, the gonadotropin-releasing hormone (GnRH) medicines segment is estimated to grow at the highest CAGR of 13.2% during the forecast period.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/47699
Based on region, North America held the largest share in 2021, contributing to nearly half of the global endometriosis market share, and is projected to maintain its dominant share in terms of revenue in 2031. In addition, the Asia-Pacific region is expected to manifest the fastest CAGR of 14.3% during the forecast period.
Leading market players of the global endometriosis market analyzed in the research include Consilient Health Limited, Serum Institute of India Pvt. Ltd., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co. Inc., Pfizer Inc., AstraZeneca plc, Abbvie Inc, Sanofi, Sun Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Ltd, Teva Pharmaceutical Industries Limited.
The report provides a detailed analysis of these key players of the global endometriosis market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Trending Reports in Healthcare Industry:
Vascular Disease Devices Market – Global Opportunity Analysis and Industry Forecast, 2020–2030
Oral Cancer Treatment Market – Global Opportunity Analysis and Industry Forecast, 2020–2030
Wearable Injectors Market – Global Opportunity Analysis and Industry Forecast, 2020–2030
Computed Tomography (CT) Market – Global Opportunity Analysis and Industry Forecast, 2020–2030
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.